Pharmacological intervention with either the MEK1 inhibitor GDC-0973 or the ERK1/2 inhibitor LY3214996 reinstated mtROS generation at later infection stages (12 h/24 h), overcoming pathogen-induced suppression (Fig. 4A). Here, MAP2K1 is linked to infection.